Napredna pretraga

Pregled bibliografske jedinice broj: 539203

Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review)


Perletti, G; Škerk, Višnja; Magri, V; Markotić, Alemka; Mazzoli, S; Parnham, MJ; Wagenlehner, FM; Naber, KG
Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review) // Molecular medicine report, 4 (2011), 6; 1035-1044 (međunarodna recenzija, članak, znanstveni)


Naslov
Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review)

Autori
Perletti, G ; Škerk, Višnja ; Magri, V ; Markotić, Alemka ; Mazzoli, S ; Parnham, MJ ; Wagenlehner, FM ; Naber, KG

Izvornik
Molecular medicine report (1791-2997) 4 (2011), 6; 1035-1044

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Prostatitis; macrolides; azithromycin; biofilm; Chlamydia trachomatis; urological infections; sexually-transmitted infections

Sažetak
Chronic bacterial prostatitis (CBP) is a persistent infection of the prostate characterized by poor quality of life mainly due to frequent relapse episodes caused by incomplete eradication of causative pathogens. Aggressive antibacterial therapy is required to attenuate the severe symptoms of CBP and to achieve a permanent cure. Although fluoroquinolones are currently recommended as first-choice agents, macrolide antibiotics are emerging as a noteworthy option for the treatment of CBP. Macrolide antibiotics are characterized by an impressive array of distinct pharmacokinetic (PK) and pharmacodynamic (PD) properties. These properties include high intracellular accumulation in phagocytes and at sites of infection, including the prostate ; broad antibiotic but also biofilm-inhibiting properties ; immunomodulating and inflammation-resolving activities. These features offer particular advantages for the treatment of chronic infections of the prostate gland, which are not easily amenable to drug therapy. Macrolides may be exploited to counteract the unsatisfactory rates of clinical symptom improvement and pathogen eradication. The results of a number of clinical trials support this proposal.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
143-1080002-0050 - Dijagnostika i liječenje bolesnika sa sindromom prostatitisa (Višnja Škerk, )
143-1430115-0103 - Imunoreakcije na hantaviruse i leptospire (Alemka Markotić, )

Ustanove
Klinika za infektivne bolesti "Dr Fran Mihaljević"

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE